Horm Metab Res 1999; 31(2/03): 126-132
DOI: 10.1055/s-2007-978709
© Georg Thieme Verlag Stuttgart · New York

Involvement of Insulin-Like Growth Factor-I in Inner Ear Organogenesis and Regeneration

Yolanda León1 , Carmen Sanz1 , Laura M. Frago1 , Guadalupe Camarero1 , Susana Cañón1 , Isabel Varela-Nieto1 , Fernando Giráldez2
  • 1Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain
  • 2Instituto de Biología y Genética Molecular (IBGM), Universidad de Valladolid-CSIC, Facultad de Medicina, Valladolid, Spain
Further Information

Publication History

1998

1998

Publication Date:
19 April 2007 (online)

The verterbrate inner ear is an excellent model system to study signalling mechanisms in embryonic development. During the last years, insulin-like growth factor-I (IGF-I) has attracted attention in relation to the regulation of inner ear ontogenesis. IGF-I and its high-affinity tyrosine-kinase receptor are expressed during early stages of inner ear development. IGF-I is a powerful mitogen for the otic vesicle, where it stimulates cell-division and mitogenic signalling cascades. Later in development, IGF-I also promotes survival and neurogenesis of the otic neurones in the cochleovestibular ganglion (CVG). The actions of IGF-I are associated with the generation of lipidic messengers and the activation of Raf kinase, which results in the rapid induction of the expression of the proliferative cell nuclear antigen (PCNA) and the nuclear proto-oncogenes c-fos and c-jun. Regulation of organogenesis involves a dynamic balance of the mechanisms regulating cell division, differentiation and death. A model is proposed where this balance is the consequence of the action of IGF-I and NGF, which converge in Raf activation or suppression. The combinatorial expression of Jun and Fos family members in particular domains of the otic vesicle would be the final result of such cascade. Some of these mechanisms may be also implicated in otic regeneration.

    >